Asset Allocation

As of November 30, 2025.
Type % Net
Cash 3.47%
Stock 96.52%
Bond 0.00%
Convertible 0.00%
Preferred 0.00%
Other 0.01%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 83.63%
Mid 11.29%
Small 5.08%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 94.71%    % Emerging Markets: 1.81%    % Unidentified Markets: 3.48%

Americas 54.36%
54.36%
Canada 0.88%
United States 53.48%
0.00%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 24.12%
United Kingdom 6.27%
17.03%
Belgium 1.52%
France 2.91%
Germany 1.90%
Ireland 3.43%
Netherlands 1.28%
Switzerland 5.98%
0.71%
Czech Republic 0.71%
0.12%
South Africa 0.12%
Greater Asia 18.04%
Japan 8.55%
0.00%
8.51%
Hong Kong 3.74%
South Korea 2.43%
Taiwan 2.34%
0.98%
China 0.98%
Unidentified Region 3.48%

Stock Sector Exposure

Cyclical
32.72%
Materials
1.82%
Consumer Discretionary
5.82%
Financials
25.03%
Real Estate
0.05%
Sensitive
47.78%
Communication Services
11.35%
Energy
5.07%
Industrials
17.64%
Information Technology
13.72%
Defensive
19.49%
Consumer Staples
9.93%
Health Care
9.54%
Utilities
0.02%
Not Classified
0.01%
Non Classified Equity
0.01%
Not Classified - Non Equity
0.00%
As of November 30, 2025
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available